Search for: "Teva Pharmaceuticals" Results 501 - 520 of 1,423
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jan 2015, 7:07 am
Breyer delivered the opinion of the Court in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Jun 2018, 3:45 am by Steve Brachmann
Regis and Allergan, appellees Mylan and Teva as well as the respondent for the U.S. federal government, without giving much clue as to whether the panel favored the argument offered by any particular side. [read post]
6 Apr 2024, 8:49 pm by Patent Docs
This year's conference co-chairs include Andrei Iancu (Partner, Sullivan & Cromwell LLP and former Director of the USPTO), Brian Malkin (Associate General Counsel, Teva Pharmaceuticals), and Mira Mulvaney (Assistant General Patent Counsel, IP Litigation, Eli Lilly & Company). [read post]
1 Jul 2008, 4:41 am
  Here, the court contrasted the facts of the case with those of the Teva v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. [read post]
10 Nov 2007, 9:26 pm
Teva and Upsher-Smith recently submitted new comments to FDA regarding acarbose 180-day exclusivity (see FDA Law Blog). [read post]
23 Jul 2012, 3:30 am
In her lawsuit, Klopp names both Wyeth (the company which makes the name-brand version of the drug) and Schwarz Pharma and Teva Pharmaceuticals (the companies which make the generic version of Reglan) as defendants. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
16 Nov 2022, 6:09 am by Anastasiia Kyrylenko
To wit, case 910/9215/21 interpreted the Law No 2174-IX to mean that patent rights, which expire while martial law is in force, shall be extended until the end of the war.In that case, the US pharmaceutical company Merck & Co. filed a lawsuit in 2021 against Teva Ukraine (a subsidiary of Israeli pharmaceutical company Teva), Merck & Co. requesting that Teva Ukraine cease infringement of Merck’s rights to a patent No 55409… [read post]
26 Oct 2011, 7:59 am by Joe Consumer
  Meanwhile, the pharmaceutical industry has had a “get out of jail free” card there ever since while sick and injured patients are kicked to the curb. [read post]
28 Mar 2012, 6:31 am
whereas in the quetiapine case only a single type of sustained release formulation was at issue, claim 1 being in the following terms: A sustained release formulation comprising a gelling agent and [quetiapine] or a pharmaceutically acceptable salt thereof, together with one or more pharmaceutically acceptable excipients. [read post]
19 Oct 2012, 9:00 am by Matthew Gilpin
One of these was Budaprion XL, made by Impax Laboratories and marketed by Teva Pharmaceuticals. [read post]
19 Oct 2017, 10:29 am by Eric Caligiuri
Teva Pharmaceuticals USA, Inc. et al, Case No. 2:15-cv-1455-WCB (EDTX October 16, 2017 Order), a Federal District Court recently invalidated several patents covering Allergan’s dry-eye drug Restasis. [read post]